During the past decade, UPMC Senior Communities conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Senior Communities" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Senior Communities" are "Osteoporosis" (2 trials), "Osteoporosis, Postmenopausal" (2 trials), "Osteoporosis Fracture" (1 trials) and "Osteoporotic Fractures" (1 trials). Many other conditions were trialed in "UPMC Senior Communities" in a lesser frequency.

Most popular intervention types in "UPMC Senior Communities" are "Dietary Supplement" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Calcium and Vitamin D" (2 trials), "Placebo" (2 trials), "Romosozumab" (1 trials), "Zoledronic Acid" (1 trials) and "Zoledronic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Senior Communities" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Senior Communities". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UPMC Senior Communities, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Senior Communities, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".